RevoNA

Revolutionizing RNA drug discovery

Revolutionizing RNA drug discovery

Unlocking the potential of RNA in treating diseases by enabling faster analysis, prediction & time-to-market for RNA targeted drugs.

LOCATION
England, Europe
Sectors
Tech Bio
Founders

Charlotte Henderson

Anastasia Callaghan

RevoNA holds huge potential in treating currently ‘undruggable’ diseases by overcoming the challenges associated with targeting RNA. Conventional approaches are slow and costly, limited by inadequate R&D tools and RNA complexity, resulting in a shortage of crucial data in the field. Next-generation technologies are essential to unlocking the necessary data to drive RNA Drug discovery forward. RevoNA’s innovative solution integrates a novel high-throughput RNA biological platform, that rapidly amasses premium RNA datasets enriched with diverse information. These comprehensive datasets feed a complementary AI prediction engine build, that will enable RevoNA to significantly reduce the time-to-market for RNA-targeted drugs and make discovery affordable at scale.

Unlocking the potential of RNA in treating diseases by enabling faster analysis, prediction & time-to-market for RNA targeted drugs.
,
IN THE NEWS
No items found.